25 XP   0   0   10

Regeneus Ltd
Buy, Hold or Sell?

Let's analyse Regeneus together

PenkeI guess you are interested in Regeneus Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Regeneus Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Regeneus Ltd

I send you an email if I find something interesting about Regeneus Ltd.

Quick analysis of Regeneus (30 sec.)










What can you expect buying and holding a share of Regeneus? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$-0.01
Expected worth in 1 year
A$-0.04
How sure are you?
30.0%

+ What do you gain per year?

Total Gains per Share
A$-0.04
Return On Investment
-419.1%

For what price can you sell your share?

Current Price per Share
A$0.01
Expected price per share
A$0.007 - A$0.02
How sure are you?
50%

1. Valuation of Regeneus (5 min.)




Live pricePrice per Share (EOD)

A$0.01

Intrinsic Value Per Share

A$0.03 - A$0.09

Total Value Per Share

A$0.02 - A$0.08

2. Growth of Regeneus (5 min.)




Is Regeneus growing?

Current yearPrevious yearGrowGrow %
How rich?-$1.1m$698.5k-$1.8m-159.2%

How much money is Regeneus making?

Current yearPrevious yearGrowGrow %
Making money-$1m-$2.8m$1.7m159.8%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Regeneus (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#878 / 1010

Most Revenue
#834 / 1010

Most Profit
#248 / 1010

Most Efficient
#273 / 1010

What can you expect buying and holding a share of Regeneus? (5 min.)

Welcome investor! Regeneus's management wants to use your money to grow the business. In return you get a share of Regeneus.

What can you expect buying and holding a share of Regeneus?

First you should know what it really means to hold a share of Regeneus. And how you can make/lose money.

Speculation

The Price per Share of Regeneus is A$0.009. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Regeneus.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Regeneus, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$-0.01. Based on the TTM, the Book Value Change Per Share is A$-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Regeneus.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-39.8%0.00-39.8%-0.01-101.6%0.00-48.7%-0.01-70.6%
Usd Book Value Change Per Share-0.01-68.1%-0.01-68.1%-0.01-72.4%0.00-22.3%0.00-41.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-68.1%-0.01-68.1%-0.01-72.4%0.00-22.3%0.00-41.3%
Usd Price Per Share0.00-0.00-0.04-0.04-0.08-
Price to Earnings Ratio-1.27--1.27--4.34--4.34--5.09-
Price-to-Total Gains Ratio-0.74--0.74--6.09--0.17--127.55-
Price to Book Ratio-1.18--1.18-17.39--29.22--10.22-
Price-to-Total Gains Ratio-0.74--0.74--6.09--0.17--127.55-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0058491
Number of shares170966
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.010.00
Usd Total Gains Per Share-0.010.00
Gains per Quarter (170966 shares)-1,047.79-343.50
Gains per Year (170966 shares)-4,191.17-1,373.99
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-4191-42010-1374-1384
20-8382-83920-2748-2758
30-12574-125830-4122-4132
40-16765-167740-5496-5506
50-20956-209650-6870-6880
60-25147-251560-8244-8254
70-29338-293470-9618-9628
80-33529-335380-10992-11002
90-37721-377290-12366-12376
100-41912-419200-13740-13750

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%2.08.00.020.0%5.09.02.031.3%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%3.07.00.030.0%7.09.00.043.8%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%4.00.012.025.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%3.07.00.030.0%7.09.00.043.8%

Fundamentals of Regeneus

About Regeneus Ltd

Regeneus Ltd, a clinical stage regenerative medicine company, develops cell-based therapies for the human health markets with a focus on osteoarthritis and other musculoskeletal disorders, neuropathic pain, and dermatology diseases in Australia. The company's platform technology includes Progenza, a multi-synergistic therapy, which has completed Phase I clinical trial for the treatment of osteoarthritis; and in pre-clinical stage to treat neuropathic pain. It also develops Sygenus that is in pre-clinical stage for the treatment of skin wound healing. The company was incorporated in 2007 and is headquartered in Paddington, Australia.

Fundamental data was last updated by Penke on 2024-04-04 23:45:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Regeneus Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Regeneus earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Regeneus to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Regeneus Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-4,629.0%+4,629.0%
5Y-4,629.0%10Y-2,533.6%-2,095.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--200.1%+200.1%
TTM--216.8%+216.8%
YOY--288.3%+288.3%
5Y-4,629.0%-449.1%-4,179.9%
10Y-2,533.6%-605.5%-1,928.1%
1.1.2. Return on Assets

Shows how efficient Regeneus is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Regeneus to the Biotechnology industry mean.
  • -236.1% Return on Assets means that Regeneus generated $-2.36 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Regeneus Ltd:

  • The MRQ is -236.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -236.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-236.1%TTM-236.1%0.0%
TTM-236.1%YOY-171.5%-64.6%
TTM-236.1%5Y-143.3%-92.8%
5Y-143.3%10Y-98.7%-44.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-236.1%-13.3%-222.8%
TTM-236.1%-12.8%-223.3%
YOY-171.5%-11.7%-159.8%
5Y-143.3%-13.9%-129.4%
10Y-98.7%-15.7%-83.0%
1.1.3. Return on Equity

Shows how efficient Regeneus is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Regeneus to the Biotechnology industry mean.
  • 0.0% Return on Equity means Regeneus generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Regeneus Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-407.7%+407.7%
TTM-5Y-71.2%+71.2%
5Y-71.2%10Y-73.8%+2.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--16.9%+16.9%
TTM--16.1%+16.1%
YOY-407.7%-15.1%-392.6%
5Y-71.2%-19.3%-51.9%
10Y-73.8%-20.2%-53.6%

1.2. Operating Efficiency of Regeneus Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Regeneus is operating .

  • Measures how much profit Regeneus makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Regeneus to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Regeneus Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-4,704.3%+4,704.3%
5Y-4,704.3%10Y-2,567.0%-2,137.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--296.2%+296.2%
TTM--232.5%+232.5%
YOY--298.2%+298.2%
5Y-4,704.3%-492.1%-4,212.2%
10Y-2,567.0%-632.4%-1,934.6%
1.2.2. Operating Ratio

Measures how efficient Regeneus is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Regeneus Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y55.502-55.502
5Y55.50210Y31.806+23.696
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.231-3.231
TTM-3.310-3.310
YOY-3.890-3.890
5Y55.5025.739+49.763
10Y31.8067.876+23.930

1.3. Liquidity of Regeneus Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Regeneus is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.28 means the company has $0.28 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Regeneus Ltd:

  • The MRQ is 0.282. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.282. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.282TTM0.2820.000
TTM0.282YOY0.533-0.251
TTM0.2825Y1.447-1.165
5Y1.44710Y3.235-1.788
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2823.890-3.608
TTM0.2824.173-3.891
YOY0.5335.344-4.811
5Y1.4476.126-4.679
10Y3.2356.448-3.213
1.3.2. Quick Ratio

Measures if Regeneus is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Regeneus to the Biotechnology industry mean.
  • A Quick Ratio of 0.27 means the company can pay off $0.27 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Regeneus Ltd:

  • The MRQ is 0.271. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.271. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.271TTM0.2710.000
TTM0.271YOY0.536-0.265
TTM0.2715Y1.539-1.268
5Y1.53910Y2.012-0.473
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2713.514-3.243
TTM0.2713.998-3.727
YOY0.5365.380-4.844
5Y1.5396.105-4.566
10Y2.0126.404-4.392

1.4. Solvency of Regeneus Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Regeneus assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Regeneus to Biotechnology industry mean.
  • A Debt to Asset Ratio of 3.54 means that Regeneus assets are financed with 354.0% credit (debt) and the remaining percentage (100% - 354.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Regeneus Ltd:

  • The MRQ is 3.540. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 3.540. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ3.540TTM3.5400.000
TTM3.540YOY0.579+2.961
TTM3.5405Y1.836+1.704
5Y1.83610Y1.023+0.813
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.5400.339+3.201
TTM3.5400.336+3.204
YOY0.5790.271+0.308
5Y1.8360.366+1.470
10Y1.0230.389+0.634
1.4.2. Debt to Equity Ratio

Measures if Regeneus is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Regeneus to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Regeneus Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY1.377-1.377
TTM-5Y0.486-0.486
5Y0.48610Y0.390+0.096
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.388-0.388
TTM-0.402-0.402
YOY1.3770.335+1.042
5Y0.4860.426+0.060
10Y0.3900.461-0.071

2. Market Valuation of Regeneus Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Regeneus generates.

  • Above 15 is considered overpriced but always compare Regeneus to the Biotechnology industry mean.
  • A PE ratio of -1.27 means the investor is paying $-1.27 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Regeneus Ltd:

  • The EOD is -1.635. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.272. Based on the earnings, the company is expensive. -2
  • The TTM is -1.272. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.635MRQ-1.272-0.363
MRQ-1.272TTM-1.2720.000
TTM-1.272YOY-4.337+3.066
TTM-1.2725Y-4.336+3.065
5Y-4.33610Y-5.089+0.752
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.635-2.264+0.629
MRQ-1.272-2.629+1.357
TTM-1.272-2.680+1.408
YOY-4.337-4.145-0.192
5Y-4.336-6.257+1.921
10Y-5.089-6.254+1.165
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Regeneus Ltd:

  • The EOD is -4.176. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.248. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.248. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.176MRQ-3.248-0.928
MRQ-3.248TTM-3.2480.000
TTM-3.248YOY-4.282+1.034
TTM-3.2485Y-670.203+666.955
5Y-670.20310Y-338.721-331.482
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-4.176-2.973-1.203
MRQ-3.248-3.333+0.085
TTM-3.248-3.553+0.305
YOY-4.282-5.605+1.323
5Y-670.203-8.376-661.827
10Y-338.721-8.865-329.856
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Regeneus is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -1.18 means the investor is paying $-1.18 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Regeneus Ltd:

  • The EOD is -1.520. Based on the equity, the company is expensive. -2
  • The MRQ is -1.182. Based on the equity, the company is expensive. -2
  • The TTM is -1.182. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.520MRQ-1.182-0.338
MRQ-1.182TTM-1.1820.000
TTM-1.182YOY17.392-18.574
TTM-1.1825Y-29.220+28.038
5Y-29.22010Y-10.223-18.997
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.5201.896-3.416
MRQ-1.1822.115-3.297
TTM-1.1822.093-3.275
YOY17.3922.884+14.508
5Y-29.2203.542-32.762
10Y-10.2233.916-14.139
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Regeneus Ltd.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Regeneus Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.009-0.0090%-0.010+6%-0.003-67%-0.006-39%
Book Value Per Share---0.006-0.0060%0.004-269%-0.002-66%0.010-162%
Current Ratio--0.2820.2820%0.533-47%1.447-80%3.235-91%
Debt To Asset Ratio--3.5403.5400%0.579+511%1.836+93%1.023+246%
Debt To Equity Ratio----0%1.377-100%0.486-100%0.390-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.006-0.0060%-0.014+155%-0.007+22%-0.010+78%
Free Cash Flow Per Share---0.002-0.0020%-0.014+561%-0.003+38%-0.007+227%
Free Cash Flow To Equity Per Share--0.0010.0010%-0.015+1845%0.001-38%0.001-22%
Gross Profit Margin--1.4121.4120%1.000+41%1.106+28%1.112+27%
Intrinsic Value_10Y_max--0.085--------
Intrinsic Value_10Y_min--0.030--------
Intrinsic Value_1Y_max--0.000--------
Intrinsic Value_1Y_min---0.001--------
Intrinsic Value_3Y_max--0.006--------
Intrinsic Value_3Y_min---0.001--------
Intrinsic Value_5Y_max--0.020--------
Intrinsic Value_5Y_min--0.004--------
Market Cap2757932.928+22%2145058.9442145058.9440%18692656.512-89%18085911.268-88%36000217.820-94%
Net Profit Margin----0%-0%-46.2900%-25.3360%
Operating Margin----0%-0%-47.0430%-25.6700%
Operating Ratio----0%-0%55.502-100%31.806-100%
Pb Ratio-1.520-29%-1.182-1.1820%17.392-107%-29.220+2372%-10.223+765%
Pe Ratio-1.635-29%-1.272-1.2720%-4.337+241%-4.336+241%-5.089+300%
Price Per Share0.009+22%0.0070.0070%0.061-89%0.059-88%0.117-94%
Price To Free Cash Flow Ratio-4.176-29%-3.248-3.2480%-4.282+32%-670.203+20536%-338.721+10329%
Price To Total Gains Ratio-0.954-29%-0.742-0.7420%-6.087+720%-0.167-78%-127.548+17083%
Quick Ratio--0.2710.2710%0.536-49%1.539-82%2.012-87%
Return On Assets---2.361-2.3610%-1.715-27%-1.433-39%-0.987-58%
Return On Equity----0%-4.0770%-0.7120%-0.7380%
Total Gains Per Share---0.009-0.0090%-0.010+6%-0.003-67%-0.006-39%
Usd Book Value---1179541.204-1179541.2040%698506.671-269%-404518.427-66%1902544.296-162%
Usd Book Value Change Per Share---0.006-0.0060%-0.007+6%-0.002-67%-0.004-39%
Usd Book Value Per Share---0.004-0.0040%0.002-269%-0.001-66%0.006-162%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.004-0.0040%-0.009+155%-0.004+22%-0.006+78%
Usd Free Cash Flow---429235.554-429235.5540%-2837393.211+561%-593515.456+38%-1402238.928+227%
Usd Free Cash Flow Per Share---0.001-0.0010%-0.009+561%-0.002+38%-0.005+227%
Usd Free Cash Flow To Equity Per Share--0.0010.0010%-0.009+1845%0.001-38%0.001-22%
Usd Market Cap1792380.610+22%1394073.8081394073.8080%12148357.467-89%11754033.733-88%23396541.561-94%
Usd Price Per Share0.006+22%0.0050.0050%0.040-89%0.038-88%0.076-94%
Usd Profit---1096305.262-1096305.2620%-2848112.661+160%-1755562.782+60%-2152730.515+96%
Usd Revenue----0%-0%1138033.131-100%1551881.197-100%
Usd Total Gains Per Share---0.006-0.0060%-0.007+6%-0.002-67%-0.004-39%
 EOD+6 -2MRQTTM+0 -0YOY+17 -125Y+10 -2110Y+11 -20

4.2. Fundamental Score

Let's check the fundamental score of Regeneus Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.635
Price to Book Ratio (EOD)Between0-1-1.520
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.271
Current Ratio (MRQ)Greater than10.282
Debt to Asset Ratio (MRQ)Less than13.540
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-2.361
Total1/10 (10.0%)

4.3. Technical Score

Let's check the technical score of Regeneus Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.010
Total1/1 (100.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets714
Total Liabilities2,529
Total Stockholder Equity-1,815
 As reported
Total Liabilities 2,529
Total Stockholder Equity+ -1,815
Total Assets = 714

Assets

Total Assets714
Total Current Assets714
Long-term Assets1
Total Current Assets
Cash And Cash Equivalents 303
Net Receivables 383
Other Current Assets 28
Total Current Assets  (as reported)714
Total Current Assets  (calculated)714
+/-0
Long-term Assets
Property Plant Equipment 1
Long-term Assets  (as reported)1
Long-term Assets  (calculated)1
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities2,529
Long-term Liabilities0
Total Stockholder Equity-1,815
Total Current Liabilities
Short-term Debt 1,947
Short Long Term Debt 1,947
Accounts payable 501
Other Current Liabilities 81
Total Current Liabilities  (as reported)2,529
Total Current Liabilities  (calculated)4,476
+/- 1,947
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Common Stock38,619
Retained Earnings -42,277
Other Stockholders Equity 1,843
Total Stockholder Equity (as reported)-1,815
Total Stockholder Equity (calculated)-1,815
+/-0
Other
Capital Stock38,619
Cash and Short Term Investments 303
Common Stock Shares Outstanding 306,437
Liabilities and Stockholders Equity 714
Net Debt 1,644
Net Invested Capital 132
Net Tangible Assets -125
Net Working Capital -1,816
Property Plant and Equipment Gross 1
Short Long Term Debt Total 1,947



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302010-06-302002-06-302001-06-302000-06-301999-06-30
> Total Assets 
281,417
289,365
325,409
50,204
1,821
16,733
10,259
9,579
5,935
9,165
4,983
2,542
3,564
8,510
2,555
714
7142,5558,5103,5642,5424,9839,1655,9359,57910,25916,7331,82150,204325,409289,365281,417
   > Total Current Assets 
59,160
61,816
78,944
33,991
0
16,095
7,089
7,128
3,503
8,261
4,313
2,385
3,484
6,727
787
714
7147876,7273,4842,3854,3138,2613,5037,1287,08916,095033,99178,94461,81659,160
       Cash And Cash Equivalents 
42,577
39,104
31,674
33,483
0
14,175
2,507
3,013
529
4,135
1,092
255
982
3,793
95
303
303953,7939822551,0924,1355293,0132,50714,175033,48331,67439,10442,577
       Short-term Investments 
0
0
0
0
0
123
278
0
0
0
0
596
570
570
69
0
069570570596000027812300000
       Net Receivables 
4,200
5,495
9,909
378
533
1,522
230
158
126
1,317
896
647
1,896
2,910
558
383
3835582,9101,8966478961,3171261582301,5225333789,9095,4954,200
       Inventory 
10,096
15,945
35,240
0
26
192
206
99
30
22
15
9
12
0
40
0
04001291522309920619226035,24015,94510,096
   > Long-term Assets 
0
0
0
0
0
638
3,170
2,451
2,432
904
670
157
80
1,784
1,767
1
11,7671,784801576709042,4322,4513,17063800000
       Property Plant Equipment 
184,231
188,138
209,953
1,872
72
589
1,362
892
802
610
417
153
80
34
17
1
11734801534176108028921,362589721,872209,953188,138184,231
       Long Term Investments 
1,656
1,728
6,136
12,525
0
0
0
0
0
78
41
4
0
0
1,750
0
01,75000441780000012,5256,1361,7281,656
       Intangible Assets 
0
0
0
0
0
49
30
26
11
6
2
0
0
0
0
0
00000261126304900000
       Long-term Assets Other 
0
0
0
0
0
0
1,236
1,323
1,619
210
210
157
-1,225
-1,750
0
0
00-1,750-1,2251572102101,6191,3231,236000000
> Total Liabilities 
150,858
128,271
129,200
9,666
450
1,029
1,951
1,307
1,150
1,065
2,061
8,928
3,695
4,365
1,480
2,529
2,5291,4804,3653,6958,9282,0611,0651,1501,3071,9511,0294509,666129,200128,271150,858
   > Total Current Liabilities 
51,405
47,176
63,048
9,544
450
1,029
1,698
1,260
1,006
876
1,819
8,753
3,633
1,297
1,477
2,529
2,5291,4771,2973,6338,7531,8198761,0061,2601,6981,0294509,54463,04847,17651,405
       Short-term Debt 
121,506
41,764
29,528
0
0
0
489
253
0
0
1,000
3,780
1,105
5
1,006
1,947
1,9471,00651,1053,7801,0000025348900029,52841,764121,506
       Short Long Term Debt 
121,506
41,764
29,528
0
0
0
742
253
0
0
1,000
3,780
1,100
0
1,000
1,947
1,9471,00001,1003,7801,0000025374200029,52841,764121,506
       Accounts payable 
10,265
6,568
0
0
284
628
435
453
539
350
372
1,056
556
872
158
501
5011588725561,056372350539453435628284006,56810,265
       Other Current Liabilities 
8,348
23,826
42,178
2,798
166
95
654
438
466
508
446
7,344
1,440
419
313
81
813134191,4407,344446508466438654951662,79842,17823,8268,348
   > Long-term Liabilities 
0
0
0
0
0
0
253
48
144
189
243
175
63
3,068
3
0
033,0686317524318914448253000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
14
9
3
0
03914000000000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
0
19
14
8
0
081419000000000000
       Deferred Long Term Liability 
0
1,327
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000001,3270
> Total Stockholder Equity
127,536
155,431
182,737
39,634
1,371
15,704
8,308
8,272
4,785
8,100
2,922
-6,386
-131
4,145
1,075
-1,815
-1,8151,0754,145-131-6,3862,9228,1004,7858,2728,30815,7041,37139,634182,737155,431127,536
   Common Stock
87,576
83,670
82,034
30,762
2,490
24,978
24,909
31,077
31,077
31,077
31,077
31,077
38,156
38,259
38,619
38,619
38,61938,61938,25938,15631,07731,07731,07731,07731,07724,90924,9782,49030,76282,03483,67087,576
   Retained Earnings 
40,339
67,756
83,872
8,457
0
-10,010
-18,792
-25,296
-27,917
-24,630
-29,775
-37,875
-38,718
-34,649
-38,951
-42,277
-42,277-38,951-34,649-38,718-37,875-29,775-24,630-27,917-25,296-18,792-10,01008,45783,87267,75640,339
   Capital Surplus 0000000000000000
   Treasury Stock0000000000000000
   Other Stockholders Equity 
-379
4,005
16,831
415
0
0
2,192
2,491
1,625
1,653
1,619
412
2,229
0
1,407
1,843
1,8431,40702,2294121,6191,6531,6252,4912,1920041516,8314,005-379



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.




Income Statement

Currency in AUD. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-6
Gross Profit-6-6
 
Operating Income (+$)
Gross Profit-6
Operating Expense-2,243
Operating Income-2,249-2,249
 
Operating Expense (+$)
Research Development472
Selling General Administrative1,075
Selling And Marketing Expenses695
Operating Expense2,2432,243
 
Net Interest Income (+$)
Interest Income258
Interest Expense-350
Other Finance Cost-198
Net Interest Income-290
 
Pretax Income (+$)
Operating Income-2,249
Net Interest Income-290
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-2,673-1,825
EBIT - interestExpense = -2,599
-2,673
-1,337
Interest Expense350
Earnings Before Interest and Taxes (EBIT)-2,249-2,323
Earnings Before Interest and Taxes (EBITDA)-2,243
 
After tax Income (+$)
Income Before Tax-2,673
Tax Provision-0
Net Income From Continuing Ops-3,377-2,673
Net Income-1,687
Net Income Applicable To Common Shares-1,687
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses2,249
Total Other Income/Expenses Net-424290
 

Technical Analysis of Regeneus
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Regeneus. The general trend of Regeneus is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Regeneus's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Regeneus Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.015 < 0.016 < 0.02.

The bearish price targets are: 0.008 > 0.007 > 0.007.

Tweet this
Regeneus Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Regeneus Ltd. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Regeneus Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Regeneus Ltd.

Regeneus Ltd Daily Moving Average Convergence/Divergence (MACD) ChartRegeneus Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Regeneus Ltd. The current adx is .

Regeneus Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Regeneus Ltd.

Regeneus Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Regeneus Ltd.

Regeneus Ltd Daily Relative Strength Index (RSI) ChartRegeneus Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Regeneus Ltd.

Regeneus Ltd Daily Stochastic Oscillator ChartRegeneus Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Regeneus Ltd.

Regeneus Ltd Daily Commodity Channel Index (CCI) ChartRegeneus Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Regeneus Ltd.

Regeneus Ltd Daily Chande Momentum Oscillator (CMO) ChartRegeneus Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Regeneus Ltd.

Regeneus Ltd Daily Williams %R ChartRegeneus Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Regeneus Ltd.

Regeneus Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Regeneus Ltd.

Regeneus Ltd Daily Average True Range (ATR) ChartRegeneus Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Regeneus Ltd.

Regeneus Ltd Daily On-Balance Volume (OBV) ChartRegeneus Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Regeneus Ltd.

Regeneus Ltd Daily Money Flow Index (MFI) ChartRegeneus Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Regeneus Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-09BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-24ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-26CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-07MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-21DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-22MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-04-04MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-05SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-10WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Regeneus Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Regeneus Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose0.010
Total1/1 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Regeneus with someone you think should read this too:
  • Are you bullish or bearish on Regeneus? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Regeneus? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Regeneus Ltd

I send you an email if I find something interesting about Regeneus Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Regeneus Ltd.

Receive notifications about Regeneus Ltd in your mailbox!